AI-Driven Drug Discovery: Navigating Promise, Setbacks, and Emerging Clinical Successes
The pharmaceutical industry stands at a pivotal juncture, with artificial intelligence (AI) heralded as a...
Knowledge and News for the Global Fight Against Cancer.
The pharmaceutical industry stands at a pivotal juncture, with artificial intelligence (AI) heralded as a...
The trajectory of pediatric oncology is often defined by a series of clinical hurdles, surgical...
The 2026 American Association of Cancer Research (AACR) Annual Meeting, held in San Diego from...
London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
The landscape of pediatric oncology is often defined by stories of profound resilience, but few...
The landscape of pediatric oncology is witnessing a transformative shift as targeted immunotherapy and philanthropic...
At the prestigious 2026 AACR Annual Meeting, held as a pivotal gathering for the global...
The biopharmaceutical industry finds itself navigating a complex legal and scientific terrain this week, marked...
The selection of Rylee as a 2026 American Childhood Cancer Organization (ACCO) Ambassador marks a...
The transition from a suspected sports injury to a life-threatening oncological diagnosis represents a traumatic...